Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
National
Mark Moore

Popular Weight Loss Drugs Ozempic, Wegovy May Lower Alzheimer's Disease Risk

The active ingredient in Wegovy and Ozempic may reduce the risk of Alzheimer's disease for patients with type-2 diabetes, a study shows. (Credit: AFP)

The active ingredient in popular type-2 diabetes drugs Wegovy and Ozempic may reduce the risk of Alzheimer's disease, according to a new study.

The study by researchers at Case Western Reserve School of Medicine in Cleveland found that type-2 diabetes patients taking semaglutide "compared to seven other anti-diabetic drugs."

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.